Evidence-based approach for prevention o
β
Bassam G. Abu Jawdeh; Abbas A. Kanso; Jeffrey R. Schelling
π
Article
π
2009
π
John Wiley and Sons
π
English
β 144 KB
## Abstract The frequency of radiocontrast administration is dramatically increasing, with over 80 million doses delivered annually worldwide. Although recently developed radiocontrast agents are relatively safe in most patients, contrast nephropathy (CN) is still a major source of inβhospital and